Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-09

Clinical Trial Update: Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of solifenacin or mirabegron with local estrogen versus combination pharmacotherapy for overactive bladder; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)
  • Solifenacin (solifenacin)

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: Effect of Drug, Urinary Bladder, Overactive | Phase 4 | Status: RECRUITING